Dutch dairy giant FrieslandCampina has announced a new partnership with Glycosyn, a US-based biotechnology company that produces nutritional products from milk. Glycosyn will work with Friesland’s ingredients division, using its technology to develop new products and ingredients for use in Friesland’s infant formula brand Domo.

Tine Snels, executive director of FrieslandCampina’s ingredients division, said the partnership will allow the group develop the next generation of infant nutrition products.

“We are doing this to meet the growing global demand for high-quality ingredients. Our cooperation is a perfect example of co-creation. The first quantities for trials will be available in the current year,” added Snels.

Human milk oligosaccharides (HMOs) are specialised carbohydrates which are naturally prevalent in mother’s milk. Glycosyn has developed a technology to produce oligosaccharides from lactose and Friesland hopes to use this technology as a new ingredient in its infant formula range.